PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting · NCT06673017 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Recruiting | Phase 1 | 2026-10-08 | NCT06673017 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PanTher Therapeutics | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henry Ford Health System | Detroit | United States | 147 |
| Hoag Memorial Hospital Presbyterian | Newport Beach | United States | 4 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Northwell Health Zuckerberg Cancer Center | Lake Success | United States | 1 |
| The Alfred | Melbourne | Australia | 11 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| University of Miami Sylvester Cancer Center | Miami | United States | 9 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |
| Virginia Mason Medical Center | Seattle | United States | 111 |